跳至主要内容
临床试验/ACTRN12621000778886
ACTRN12621000778886招募中未知

Does Near Infra-Red spectroscopy Targeted Use Reduce adverse outcomes in Extremely preterm infants? (NIRTURE trial)

Western Sydney Local Health District0 个研究点目标入组 100 人开始时间: 2021年6月22日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
Hours 至 6 Hours(—)
性别
All

入选标准

  • Preterm infants (singleton or twin births) less than 29 weeks gestation who are either inborn (born at the local study site hospital) or outborn (born outside the local study site hospital) and less than 6 hours of age when admitted to the study site NICU.

排除标准

  • Infants with an antenatal or postnatal diagnosis of major congenital anomaly requiring major surgery or a genetic disorder associated with neurological impairment.
  • Multiple births beyond twins are excluded for practical reasons (sites may not have additional NIRS monitors and the rates of multiple births beyond twins in Australia and New Zealand is very low < 2%).

研究者

相似试验